Xellar Raises $50 Million Series A Financing to Build the Future of 3D Bio Intelligence

Financing will accelerate the development of human-relevant biological data infrastructure, virtual cell technologies, and next-generation drug discoveryBOSTON, June 29, 2026 /PRNewswire/ — Xellar Biosystems today announced the closing of $50 million in Series A and A+ financing to…

Read the full release →

News provided by PR Newswire.